Gainers
- Sonnet BioTherapeutics SONN stock rose 110.0% to $4.41 during Monday's pre-market session. The company's market cap stands at $3.6 million.
- Metagenomi MGX stock rose 34.05% to $2.48. The market value of their outstanding shares is at $92.8 million.
- Innate Pharma IPHA shares increased by 25.17% to $1.84. The company's market cap stands at $148.9 million.
- CervoMed CRVO shares increased by 20.82% to $14.39. The company's market cap stands at $118.7 million.
- Streamline Health Solns STRM shares moved upwards by 16.71% to $3.77. The market value of their outstanding shares is at $15.9 million.
- Kodiak Sciences KOD shares increased by 14.22% to $8.94. The company's market cap stands at $470.6 million.
Losers
- Bioage Labs BIOA stock decreased by 72.1% to $5.6 during Monday's pre-market session. The company's market cap stands at $200.7 million.
- Universe Pharmaceuticals UPC shares fell 51.33% to $1.65. The company's market cap stands at $2.6 million.
- Radiopharm Theranostics RADX shares fell 40.22% to $11.3. The company's market cap stands at $24.5 billion.
- Revance Therapeutics RVNC shares decreased by 20.69% to $3.03. The company's market cap stands at $317.8 million.
- Invizyne Technologies IZTC shares fell 18.36% to $10.81. The market value of their outstanding shares is at $103.0 million.
- Psyence Biomedical PBM stock declined by 16.46% to $1.98. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CRVOCervoMed Inc
$2.16-6.43%
IPHAInnate Pharma SA
$1.891.61%
IZTCInvizyne Technologies Inc
$12.10-8.82%
KODKodiak Sciences Inc
$8.74-8.67%
MGXMetagenomi Inc
$3.24-1.82%
PBMPsyence Biomedical Ltd
$1.84-3.66%
RADXRadiopharm Theranostics Ltd
$4.03-13.3%
RVNCRevance Therapeutics Inc
$3.31-2.93%
SONNSonnet BioTherapeutics Holdings Inc
$1.62-8.99%
STRMStreamline Health Solutions Inc
$4.105.94%
UPCUniverse Pharmaceuticals Inc
$0.6215-2.89%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in